Kringle Pharma, Inc.'s total assets for Q2 2025 were ¥2.29B, a decrease of -10.01% from the previous quarter. JP:4884 total liabilities were ¥681.40M for the fiscal quarter, a 5.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.